Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin

被引:14
|
作者
Monzen, Hajime
Hara, Masatake
Hirata, Makoto
Nakanishi, Akira
Ogasawara, Makoto
Suzuki, Takatoshi
Sato, Tamie
Shimoyama, Hisashi
Tadehara, Futoshi
Hirose, Kunihiko
Yuki, Rumio
机构
[1] Otsu Red Cross Hosp, Dept Radiol, Otsu, Shiga 5208511, Japan
[2] Otsu Red Cross Hosp, Dept Cardiol, Otsu, Shiga 5208511, Japan
关键词
single-photon emission tomography; technetium-99m sestamibi; technetium-99m tetrofosmin; body position; scattered rays;
D O I
10.1007/BF02984684
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We have devised a new position (Monzen position) which can suppress the influence of scattered rays from surrounding organs (liver, etc.) when conducting myocardial imaging. Unlike the conventional techniques, which require a waiting period of 30-60 minutes before imaging can be started after the infusion of technetium-99m sestamibi or technetium-99m tetrofosmin, this position allows single-photon emission tomography to be started about 5-10 minutes after the infusion of the tracer. Therefore, with this technique the total time required for imaging is reduced and consequently the physical and mental burden of the patient is also reduced. Furthermore, the number of patients who can receive this test at any facility can be increased. This position may also be applicable in myocardial scintigraphy using some other tracers.
引用
收藏
页码:705 / 710
页数:6
相关论文
共 50 条
  • [31] Artifactual reverse distribution pattern in myocardial perfusion SPECT with technetium-99m sestamibi
    Whemberton Araujo
    E. Gordon DePuey
    Mohammad Kamran
    Manish Undavia
    Marvin Friedman
    Journal of Nuclear Cardiology, 2000, 7 : 633 - 638
  • [32] Artifactual reverse distribution pattern in myocardial perfusion SPECT with technetium-99m sestamibi
    Araujo, W
    DePuey, EG
    Kamran, M
    Undavia, M
    Friedman, M
    JOURNAL OF NUCLEAR CARDIOLOGY, 2000, 7 (06) : 633 - 638
  • [33] Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients
    Mohagheghie, A.
    Ahmadabadi, M. N.
    Hedayat, D. K.
    Pourbehi, M. R.
    Assadi, M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (01): : 3 - 8
  • [34] Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion Imaging
    Elhendy, A
    van Domburg, RT
    Vantrimpont, P
    Poldermans, D
    Bax, JJ
    van Gelder, T
    Baan, CC
    Schinkel, A
    Roelandt, JRTC
    Balk, AHMM
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (08): : 964 - 968
  • [35] Technetium-99m labeled myocardial perfusion imaging agents
    Jain, D
    SEMINARS IN NUCLEAR MEDICINE, 1999, 29 (03) : 221 - 236
  • [36] Technetium-99m sestamibi uptake in hepatocellular carcinoma
    Derebek, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (11): : 1587 - 1588
  • [37] Diffuse breast uptake of technetium-99m tetrofosmin during myocardial perfusion imaging in a lactating mother
    Khan, Muhammad Taha
    Sultan, Fateh Ali Tipoo
    BMJ CASE REPORTS, 2021, 14 (01)
  • [38] Resting Technetium-99m Sestamibi Myocardial Washout in Patients with Ischemic Heart Disease
    Tsueda, H.
    Nakazawa, Y.
    Nakamura, T.
    Moriwaki, I.
    Shiomura, Y.
    Okamoto, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S484 - S484
  • [39] DIAGNOSTIC AND PROGNOSTIC VALUE OF TECHNETIUM-99M PYROPHOSPHATE MYOCARDIAL SCINTIGRAPHY
    MATHIS, I
    ROSSO, U
    TORTA, F
    SCASSA, R
    MINERVA CARDIOANGIOLOGICA, 1980, 28 (09): : 585 - 598
  • [40] VALUE OF MYOCARDIAL SCINTIGRAPHY WITH TECHNETIUM-99M PYROPHOSPHATE IN DILATATIVE CARDIOMYOPATHY
    BLAZEK, G
    KAINZ, W
    PORADEK, T
    KAHN, P
    ACTA MEDICA AUSTRIACA, 1984, 11 : 171 - 172